4.5 Article

MIRA-seq for DNA methylation analysis of CpG islands

Journal

EPIGENOMICS
Volume 7, Issue 5, Pages 695-706

Publisher

FUTURE MEDICINE LTD
DOI: 10.2217/epi.15.33

Keywords

CpG islands; DNA methylation; high-throughput sequencing; methyl-CpG-binding protein; methylated-CpG island recovery assay

Funding

  1. NIH [AG036041, CA160965, CA084469]
  2. NATIONAL CANCER INSTITUTE [R01CA084469, R01CA160965] Funding Source: NIH RePORTER
  3. NATIONAL INSTITUTE ON AGING [R01AG036041] Funding Source: NIH RePORTER

Ask authors/readers for more resources

To develop a reliable method for whole genome analysis of DNA methylation. Materials & methods: Genome-scale analysis of DNA methylation includes affinity-based approaches such as enrichment using methyl-CpG-binding proteins. One of these methods, the methylated-CpG island recovery assay (MIRA), is based on the high affinity of the MBD2b-MBD3L1 complex for CpG-methylated DNA. Here we provide a detailed description of MIRA and combine it with next generation sequencing platforms (MIRA-seq). Results: We assessed the performance of MIRA-seq and compared the data with whole genome bisulfite sequencing. Conclusion: MIRA-seq is a reliable, genome-scale DNA methylation analysis platform for scoring DNA methylation differences at CpG-rich genomic regions. The method is not limited by primer or probe design and is cost effective.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available